Brady James Aloysius

Director at Xeris Biopharma Holdings, Inc. · on record since Apr 1, 2026
Director at Verona Pharma plc · on record since Mar 16, 2022

Insider trading activity of Brady James Aloysius

Transactions on record: 18; since Mar 16, 2022

Open-market buys: 0

Open-market sells: 2; $70.9K

Companies traded: 2; last filing Jun 5, 2026

Figures computed from official regulatory filings — .

Companies where Brady James Aloysius has traded

Xeris Biopharma Holdings, Inc.4 tx · $263K · Jun 5, 2026
Verona Pharma plc14 tx · $10.8K · Oct 8, 2025

Track record of Brady James Aloysius

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Brady James Aloysius

Co-insiders of Brady James Aloysius

Access Industries Holdings LLCVerona Pharma plc
ACCESS INDUSTRIES MANAGEMENT, LLCVerona Pharma plc
ACKERMANN CHRISTINAVerona Pharma plc
AI Biotechnology LLCVerona Pharma plc
Austwick MichaelVerona Pharma plc
BASKETT FORESTVerona Pharma plc
Blavatnik LenVerona Pharma plc
Cunningham KennethVerona Pharma plc
Deschamps LisaVerona Pharma plc
EBSWORTH DAVID RVerona Pharma plc
Edwards MartinVerona Pharma plc
Fairley Ricki LouiseXeris Biopharma Holdings, Inc.
Fisher AndrewVerona Pharma plc
Florence Anthony A. Jr.Verona Pharma plc
Gupta RishiVerona Pharma plc
Hahn Mark WVerona Pharma plc
Hecht BethXeris Biopharma Holdings, Inc.
Johnson John HXeris Biopharma Holdings, Inc.
Kong GarhengXeris Biopharma Holdings, Inc.
KREHER NERISSAXeris Biopharma Holdings, Inc.
Makhzoumi MohamadVerona Pharma plc
MAKOWER JOSHUAVerona Pharma plc
McCulloch KevinXeris Biopharma Holdings, Inc.
Nguyen Anh TuXeris Biopharma Holdings, Inc.
ORBIMED ADVISORS LLCVerona Pharma plc

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	Award	24,193	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	AwardD (derivative)	32,996	6.15 USD	$202.9K	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Apr 1, 2026	Sell	-10,834	5.54 USD	$60K	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	ExerciseD (derivative)	-72,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	OtherD (derivative)	-240,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	OtherD (derivative)	-288,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	OtherD (derivative)	-96,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	Other	-72,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	Exercise	72,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	Other	-23,176	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Aug 5, 2025	ExerciseD (derivative)	-24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Aug 5, 2025	Exercise	24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Aug 5, 2025	Sell	-824	13.14 USD	$10.8K	SEC
Verona Pharma plcListing unverified	Apr 29, 2025	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Mar 28, 2025	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Apr 30, 2024	AwardD (derivative)	240,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Apr 28, 2023	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Mar 16, 2022	AwardD (derivative)	288,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	Award	24,193	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	AwardD (derivative)	32,996	6.15 USD	$202.9K	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Apr 1, 2026	Sell	-10,834	5.54 USD	$60K	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	ExerciseD (derivative)	-72,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	OtherD (derivative)	-240,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	OtherD (derivative)	-288,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	OtherD (derivative)	-96,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	Other	-72,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	Exercise	72,000	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Oct 8, 2025	Other	-23,176	—	n/a (No price was disclosed in the filing)	SEC
Verona Pharma plcListing unverified	Aug 5, 2025	ExerciseD (derivative)	-24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Aug 5, 2025	Exercise	24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Aug 5, 2025	Sell	-824	13.14 USD	$10.8K	SEC
Verona Pharma plcListing unverified	Apr 29, 2025	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Mar 28, 2025	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Apr 30, 2024	AwardD (derivative)	240,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Apr 28, 2023	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verona Pharma plcListing unverified	Mar 16, 2022	AwardD (derivative)	288,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC